ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	28420387	S13P	HBZ	pX	Paraparesis, Tropical Spastic	G R S C	View
2	23800288	C101T	HBZ	pX	Paraparesis, Tropical Spastic	R S C L	View
3	23800288	C336T	HBZ	pX	Paraparesis, Tropical Spastic	R S C L	View
4	23800288	R112C	HBZ	pX	Paraparesis, Tropical Spastic	R S C L	View
5	23800288	S9P	HBZ	pX	Paraparesis, Tropical Spastic	R S C L	View
6	23800288	T95I	HBZ	pX	Paraparesis, Tropical Spastic	R S C L	View
7	33835501	C272T	HBZ	pX	HTLV-1 Infection Paraparesis, Tropical Spastic	R S L	View
8	33835501	C585T	HBZ	pX	HTLV-1 Infection Paraparesis, Tropical Spastic	R S L	View
9	33835501	G434A	HBZ	pX	HTLV-1 Infection Paraparesis, Tropical Spastic	R S L	View
10	33835501	I164V	HBZ	pX	HTLV-1 Infection Paraparesis, Tropical Spastic	R S L	View
11	33835501	K184R	HBZ	pX	HTLV-1 Infection Paraparesis, Tropical Spastic	R S L	View
12	33835501	P65L	HBZ	pX	HTLV-1 Infection Paraparesis, Tropical Spastic	R S L	View
13	33835501	R119Q	HBZ	pX	HTLV-1 Infection Paraparesis, Tropical Spastic	R S L	View
14	33835501	T138C	HBZ	pX	HTLV-1 Infection Paraparesis, Tropical Spastic	R S L	View
15	33835501	T77C	HBZ	pX	HTLV-1 Infection Paraparesis, Tropical Spastic	R S L	View
16	33835501	V15M	HBZ	pX	HTLV-1 Infection Paraparesis, Tropical Spastic	R S L	View
17	39279426	I164V	HBZ	pX	Paraparesis, Tropical Spastic Carrier State	L	View
18	39279426	K184R	HBZ	pX	Paraparesis, Tropical Spastic Carrier State	L	View
19	39279426	P65L	HBZ	pX	Paraparesis, Tropical Spastic Carrier State	L	View
20	39279426	R119Q	HBZ	pX	Paraparesis, Tropical Spastic Carrier State	L	View
21	39279426	V15M	HBZ	pX	Paraparesis, Tropical Spastic Carrier State	L	View

Contents
Description

The table shows all curated mutation sites of HTLV1 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.